Your browser doesn't support javascript.
loading
Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method.
Khajavinia, Amir; Michel, Deborah; Ezeaka, Udoka C; Purves, Randy W; Laprairie, Robert B; El-Aneed, Anas.
Affiliation
  • Khajavinia A; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Michel D; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Ezeaka UC; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
  • Purves RW; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; Canadian Food Inspection Agency, Saskatoon, Saskatchewan S7N 2R3, Canada.
  • Laprairie RB; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; Department of Pharmacology, College of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.
  • El-Aneed A; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada. Electronic address: anas.el-aneed@usask.ca.
J Chromatogr A ; 1730: 465123, 2024 Aug 16.
Article in En | MEDLINE | ID: mdl-38981146
ABSTRACT
Psilocybin is a psychedelic compound found in some hallucinogenic "magic mushrooms". Psilocin is the active metabolite of Psilocybin, and it is the subject of several studies for the treatment of psychological disorders, such as anxiety, depression, and post-traumatic stress disorder. As such, the pharmacokinetic properties of psilocin should be evaluated to ensure its safety and efficacy as part of the drug development process. Based on the previously published studies, reversed-phase liquid chromatography (LC) was tested for psilocin quantification. The analysis, however, showed a major interference in mouse plasma that was not, to the best of our knowledge, reported previously. We, therefore, aimed to identify and separate the interference, using various chromatographic columns, mobile phase conditions, and mass spectrometers (MS) instruments. Chromatographic separation was achieved on an ultra high performance liquid chromatography (UHPLC) system, and a quadrupole-linear ion trap equipped with an electrospray ionization (ESI) source was used in positive ion mode with multiple reaction monitoring (MRM). Several chromatographic conditions and column chemistries, including C-18 and Phenyl-hexyl were initially tested, and failed to separate the interference. Exact mass measurement and MS/MS analysis were used to determine the structure of the interfering compound, which was confirmed to be tryptophan. Using the identified structure of the interfering compound, a fast and reliable hydrophilic interaction liquid chromatography (HILIC)-MS/MS method was developed and validated, that was capable of separating psilocin from the interference while achieving a 0.5 ng/ml lower limit of quantification (LLOQ). The validated method was successfully applied to a pharmacokinetic study where psilocin was orally administered to C57BL/6 mouse subjects. Psilocin concentration in all the analyzed mouse plasma samples was successfully determined.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psilocybin / Tandem Mass Spectrometry Limits: Animals Language: En Journal: J Chromatogr A Year: 2024 Document type: Article Affiliation country: Canada Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psilocybin / Tandem Mass Spectrometry Limits: Animals Language: En Journal: J Chromatogr A Year: 2024 Document type: Article Affiliation country: Canada Country of publication: Netherlands